Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Debt (2020 - 2025)

Journey Medical (DERM) has disclosed Total Debt for 6 consecutive years, with $25.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Debt rose 27.16% year-over-year to $25.2 million, compared with a TTM value of $25.2 million through Sep 2025, up 27.16%, and an annual FY2024 reading of $24.9 million, up 70.15% over the prior year.
  • Total Debt was $25.2 million for Q3 2025 at Journey Medical, roughly flat from $25.1 million in the prior quarter.
  • Across five years, Total Debt topped out at $25.2 million in Q3 2025 and bottomed at $812000.0 in Q4 2021.
  • Average Total Debt over 5 years is $17.5 million, with a median of $17.4 million recorded in 2021.
  • The sharpest move saw Total Debt tumbled 84.44% in 2021, then surged 2704.68% in 2022.
  • Year by year, Total Debt stood at $812000.0 in 2021, then soared by 2704.68% to $22.8 million in 2022, then tumbled by 35.8% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then grew by 1.13% to $25.2 million in 2025.
  • Business Quant data shows Total Debt for DERM at $25.2 million in Q3 2025, $25.1 million in Q2 2025, and $25.0 million in Q1 2025.